GenMark Diagnostics (NASDAQ:GNMK) announced its quarterly earnings results on Tuesday. The medical equipment provider reported ($0.26) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.26), Yahoo Finance reports. The firm had revenue of $16.02 million for the quarter, compared to analysts’ expectations of $15.82 million. GenMark Diagnostics had a negative net margin of 116.76% and a negative return on equity of 100.33%.
GenMark Diagnostics (GNMK) traded up $0.32 during midday trading on Wednesday, hitting $4.85. 446,100 shares of the stock were exchanged, compared to its average volume of 472,992. GenMark Diagnostics has a twelve month low of $3.63 and a twelve month high of $13.67. The company has a current ratio of 2.97, a quick ratio of 2.77 and a debt-to-equity ratio of 0.12. The firm has a market capitalization of $248.22, a PE ratio of -3.98 and a beta of 0.78.
In related news, CFO Scott Mendel sold 6,275 shares of GenMark Diagnostics stock in a transaction on Monday, February 26th. The shares were sold at an average price of $4.17, for a total value of $26,166.75. Following the completion of the sale, the chief financial officer now owns 246,161 shares in the company, valued at $1,026,491.37. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Hany Massarany sold 6,584 shares of GenMark Diagnostics stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $4.37, for a total transaction of $28,772.08. Following the completion of the sale, the insider now owns 357,190 shares of the company’s stock, valued at approximately $1,560,920.30. The disclosure for this sale can be found here. Over the last three months, insiders have sold 50,322 shares of company stock worth $218,938. Corporate insiders own 7.50% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “GenMark Diagnostics (GNMK) Announces Earnings Results” was first published by Ticker Report and is owned by of Ticker Report. If you are reading this piece on another domain, it was illegally copied and republished in violation of international trademark and copyright legislation. The legal version of this piece can be viewed at https://www.tickerreport.com/banking-finance/3227977/genmark-diagnostics-gnmk-announces-earnings-results.html.
GenMark Diagnostics Company Profile
GenMark Diagnostics, Inc is a molecular diagnostics company. The Company is focused on developing and commercializing multiplex molecular tests that aid in the diagnosis of complex medical conditions. It develops and commercializes multiplex molecular tests based on its eSensor electrochemical detection technology.
Receive News & Ratings for GenMark Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GenMark Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.